Greg Tourangeau - 11 Mar 2022 Form 3 Insider Report for Fulcrum Therapeutics, Inc. (FULC)

Role: Controller
Signature: /s/ Gregory Tourangeau
Issuer symbol: FULC
Transactions as of: 11 Mar 2022
Net transactions value: $0
Form type: 3
Filing time: 14 Mar 2022, 16:15:29 UTC
Next filing: 10 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	FULC	Common Stock						12,952	11 Mar 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	FULC	Stock Option (right to buy)							11 Mar 2022	Common Stock	685	$7.84	Direct	F1
holding	FULC	Stock Option (right to buy)							11 Mar 2022	Common Stock	1,339	$11.06	Direct	F2
holding	FULC	Stock Option (right to buy)							11 Mar 2022	Common Stock	374	$16.00	Direct	F3
holding	FULC	Stock Option (right to buy)							11 Mar 2022	Common Stock	3,410	$16.87	Direct	F4
holding	FULC	Stock Option (right to buy)							11 Mar 2022	Common Stock	7,278	$13.09	Direct	F5
holding	FULC	Stock Option (right to buy)							11 Mar 2022	Common Stock	9,868	$12.46	Direct	F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The reporting person received an option to purchase a total of 2,192 shares on January 22, 2019. 1,507 shares underlying the option were previously exercised by the reporting person. The shares underlying the option are scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2019, subject to continued service.
F2	The reporting person received an option to purchase a total of 3,571 shares on May 21, 2019. 2,232 shares underlying the option were previously exercised by the reporting person. The shares underlying the option are scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of May 15, 2019, subject to continued service.
F3	This option was granted on July 18, 2019 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of July 1, 2019, subject to continued service.
F4	This option was granted on January 23, 2020 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2020, subject to continued service.
F5	This option was granted on January 25, 2021 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2021, subject to continued service.
F6	This option was granted on January 26, 2022 and is scheduled to vest in equal quarterly installments over four years beginning on the vesting commencement date of January 1, 2022, subject to continued service.